Dear Editor, We read with interest the letter by Narayan et al. 1 on the variable response of NB-UVB phototherapy in different body sites in non-segmental vitiligo. This was a well-conducted multicentre study and the authors have delineated four body regions, that is face, torso and limbs, axillae and hands and feet, as distinct sites showing different rates of median repigmentation (76%, 40%, 27% and 4%, respectively).An important determinant of this differential treatment response emerges from the presence or absence of pigmented hair. Acral regions, characterized by significantly lower hair follicle density and inherently lower melanocyte density, are more resistant to phototherapy. 2 Consequently, differentiating body areas into glabrous versus hair-bearing sites assumes paramount significance when contemplating treatment outcomes in non-segmental vitiligo. Furthermore, consideration should be given to the presence or absence of leukotrichia, as pigmented hairs harbour a robust melanocyte reservoir, thereby increasing the likelihood of a favourable response to phototherapy. 3 The authors' observation regarding a significantly higher repigmentation rate, reaching approximately 80%, in the lower face region compared to the lower limbs (which achieved around 64% repigmentation) is quite noteworthy. It's important to note that the lips are part of the lower face, and this area is notorious for its generally poor response to both medical management and phototherapy. This poor response is primarily due to the absence of hair follicles and a paucity of melanocyte reservoir. 4,5 Given this context, the intriguing aspect here lies in the high repigmentation rate observed in the lower face, especially considering the involvement of the lips. It would be interesting to know the specific repigmentation rates of the lips themselves, as this could provide valuable insights into the dynamics of vitiligo treatment outcomes in this challenging area.Other authors have also reported similar findings, emphasizing the variable response of different body sites. In a systematic review, it was shown that the most responsive body site was the face and neck, with a notable repigmentation rate of 44.2%. This was followed by the trunk (26.1%), extremities (17.3%) and hands and feet (0%). However, these authors have also identified potential confounding factors, such as disease activity, autoimmune status, the extent of involved body surface area and the presence of poliosis, which could influence treatment outcomes. 6